Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Nurse-Led AI-Supported Psychosocial Support for Palliative Caregivers

28. August 2026 aktualisiert von: Havva Kaçan, Kastamonu University

The Effect of a Nurse-Led, Generative AI-Supported Individualized Psychosocial Support Program on the Care Readiness and Psychological Resilience of Primary Caregivers of Palliative Care Patients

Primary caregivers of palliative care patients assume responsibility for meeting the patient's needs, monitoring symptoms, maintaining care practices, and managing changing needs. Increased responsibilities, uncertainty, and lack of information and support can negatively impact caregivers' psychosocial adjustment. The aim of this research is to evaluate the impact of a nurse-led, generative artificial intelligence-supported individualized psychosocial support program on the care readiness and psychological resilience levels of primary caregivers of palliative care patients. The six-week program will consist of six modules: adaptation to the care role, understanding care needs and coping with uncertainty, stress and emotion regulation, adaptive coping and problem-solving, self-care and social support, and making sense of the care experience and supporting strengths. Standard content, which will be evaluated with expert opinion, will be individualized according to the caregivers' needs and responses during the program. Generative artificial intelligence will be used as a nurse-supervised psychoeducational support tool within the framework of a validated knowledge base and safety rules. The research will be conducted using a pre-test-post-test, parallel-group randomized controlled experimental design. A total of 88 primary caregivers will be assigned to experimental and control groups in a 1:1 ratio. The control group will receive routine care and information, while the experimental group will receive these in addition to a psychosocial support program. Data will be collected before and immediately after the intervention using the Caregiver Demographic Information Form, the Caregiver Readiness Scale, and the Psychological Resilience Scale for Adults. Additionally, the overall satisfaction levels of participants in the experimental group regarding the program will be evaluated using a scale of 1-10. The findings are expected to provide scientific evidence for the development of individualized nursing interventions that support caregivers' preparation for the caregiving role and their psychological resilience, and for the safe, effective, and human-supervised use of generative artificial intelligence.

Studienübersicht

Detaillierte Beschreibung

This randomized controlled trial will evaluate the effect of a nurse-led, generative artificial intelligence (AI)-supported individualized psychosocial support program on the care readiness and psychological resilience of primary caregivers of patients receiving palliative care. Palliative care is a holistic approach that aims to improve the quality of life of patients and their families facing problems associated with life-threatening illnesses through the early identification, accurate assessment, and treatment of pain and other physical, psychosocial, and spiritual problems (WHO, 2020). Palliative care also includes a team-based approach that provides support to patients, their families, and caregivers. Primary caregivers undertake a substantial proportion of patients' daily living and care needs, including assistance with activities of daily living and self-care, medication management, communication with healthcare professionals, and emotional, social, and spiritual support (Pinto et al., 2026).

As the disease progresses, increasing caregiving responsibilities, uncertainty about the future, and the possibility of death may result in considerable physical, emotional, and psychosocial challenges for caregivers. Caregivers may not always feel adequately prepared for the caregiving role and may experience difficulties accessing the support they need (Hudson, 2003; McAndrew et al., 2023). These challenges may become particularly evident during the transition from hospital to home. Previous research involving palliative care patients and their caregivers has shown that positive transition experiences are associated with adequate support, the ability to manage medications, and the fulfillment of healthcare needs, whereas unclear caregiving responsibilities, medication-related confusion, uncertainty, and emotional distress may complicate the transition process (Saunders et al., 2021). Caregiver needs also continue after discharge, including adaptation to changing caregiving responsibilities, emotional regulation, coping with difficulties, use of available support resources, and maintenance of self-care (Hudson, 2003; McAndrew et al., 2023).

Care readiness is an important factor influencing caregivers' ability to participate effectively in the caregiving process. Care readiness refers to the extent to which caregivers perceive themselves as prepared to fulfill the physical, emotional, and practical requirements of the caregiving role and to cope with the stress associated with caregiving (Karaman & Karadakovan, 2015). Higher levels of care readiness have been associated with lower levels of depression and caregiver burden among caregivers of individuals with Alzheimer's disease and related dementias (Hancock et al., 2022). Among family caregivers of patients with advanced cancer, support from healthcare professionals and communication about the illness have also been associated with higher levels of care readiness (Häger Tibell et al., 2024). A systematic review and meta-analysis indicated that psychoeducational, educational, supportive, and self-care-oriented interventions may have beneficial effects on caregivers' readiness for caregiving (Bilgin & Özdemir, 2022). Similarly, an intervention based on the identification of individual caregiver support needs was associated with a significant increase in care readiness scores following the intervention (Norinder et al., 2024). However, a web-based psychoeducational intervention for family caregivers of patients receiving palliative home care did not demonstrate a significant effect on care readiness compared with the control group, potentially due to limited user engagement; the authors recommended greater integration of such programs into clinical care processes (Bauman et al., 2025).

Psychological resilience represents another important psychosocial resource associated with adaptation to caregiving. Psychological resilience refers to an individual's capacity to adapt to adversity, maintain functioning, and recover following stressful experiences. It is considered a multidimensional construct involving self-perception, future orientation, behavioral and structural characteristics, social skills, family functioning, and social support (Basım & Çetin, 2011). Among family caregivers of patients with advanced cancer, higher psychological resilience has been associated with greater care readiness and lower levels of anxiety and depressive symptoms (Dionne-Odom et al., 2021). Among family caregivers of patients in the terminal stage, adaptive coping strategies such as active coping, acceptance, positive reframing, planning, and humor have been associated with higher psychological resilience (Shimizu et al., 2025). Psychoeducational interventions may support caregivers' ability to cope with caregiving-related stress and promote psychological adaptation. In a quasi-experimental study of caregivers of patients with amyotrophic lateral sclerosis, a six-week online psychoeducational program resulted in significantly higher psychological resilience and self-compassion scores in the intervention group compared with the control group (Duran & Aydoğdu, 2024). Similarly, a randomized controlled trial among caregivers of adolescents and young adults with cancer found that a psychoeducational intervention delivered through mobile instant messaging reduced unmet caregiver needs, anxiety, and depressive symptoms (Cheng et al., 2024).

Generative AI may provide opportunities to deliver individualized explanations, case examples, and psychoeducational feedback according to caregivers' needs. However, because generative AI systems have important limitations regarding accuracy and reliability, they should not replace clinical assessment by nurses or other healthcare professionals and should be used under appropriate professional supervision (Tischendorf et al., 2025). In a study evaluating a domain-specific generative AI agent developed to support families of children and adolescents with anorexia nervosa, 91.6% of 477 responses were considered clinically appropriate by experts. However, the study was limited to system development and expert evaluation, and its effects on caregivers' psychosocial outcomes were not examined (Hanzawa et al., 2026). AI-supported systems in palliative care may have potential to provide patients and caregivers with information, emotional support, and practical assistance (Jafari Dehnayebi et al., 2026). A scoping review of AI applications for individuals with serious illnesses and their family caregivers in home settings indicated that these technologies may facilitate individualized care, continuity of care, emotional support, and caregiver support. Nevertheless, most existing studies have focused on feasibility, usability, and user experience, while research evaluating clinical and psychosocial outcomes remains limited (Xiao et al., 2026). Furthermore, a systematic review of AI applications in palliative care reported that 86% of the included studies were retrospective or proof-of-concept studies, with only seven randomized controlled trials and six prospective studies identified. These limitations highlight the need for controlled studies evaluating the effects of AI-supported interventions on psychosocial outcomes among caregivers in palliative care (Bozkurt et al., 2025).

In this trial, generative AI will be used as a nurse-supervised supportive tool rather than as an autonomous clinical decision-maker. The intervention content will be developed by the research team and validated through expert review. Predefined safety rules and standardized core content will be used throughout the intervention. The six-week program will consist of six modules: (1) adaptation to the caregiving role and care readiness, (2) understanding caregiving needs and coping with uncertainty, (3) stress management and emotional regulation, (4) adaptive coping and problem solving, (5) self-care and social support, and (6) meaning-making and strengthening personal resources related to the caregiving experience. The standardized core content will be maintained for all participants, while explanations, information cards, case examples, brief exercises, mini-questions, and psychoeducational feedback will be individualized according to the caregiver's psychosocial needs, caregiving experience, responses during the program, and basic characteristics of the patient's care needs.

The generative AI system will not independently diagnose psychological or clinical conditions, make treatment decisions, modify medical treatment, or replace professional nursing assessment. The nurse will maintain an active supervisory role throughout the intervention and will evaluate participant responses according to predefined monitoring procedures. When responses indicate a need for clinical assessment, additional psychological support, or referral to another healthcare professional, the nurse will initiate the appropriate referral process.

The primary outcomes of the trial will be care readiness and psychological resilience among primary caregivers of palliative care patients. Changes in these outcomes will be evaluated between the intervention and control groups at predefined assessment time points. The study aims to determine whether a nurse-led, generative AI-supported individualized psychosocial support program can improve caregivers' preparedness for the caregiving role and psychological resilience.

By evaluating a professionally supervised generative AI-supported psychosocial intervention in a randomized controlled design, this study is expected to contribute empirical evidence to the limited literature on the clinical and psychosocial effectiveness of generative AI interventions for caregivers in palliative care.

Studientyp

Interventionell

Einschreibung (Geschätzt)

88

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Havva KAÇAN, associate professor
  • Telefonnummer: 0366 280 4133 0366 280 4133
  • E-Mail: hkacan@kastamonu.edu.tr

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Aged 18 years or older. Being the primary caregiver of a patient receiving palliative care. Providing unpaid caregiving. Being able to read, understand, and communicate in Turkish. Having sufficient cognitive and communication abilities to complete the data collection instruments.

Being able to use the generative AI-supported program with the explanation and technical support provided by the researcher, when necessary.

Voluntarily agreeing to participate in the six-week intervention program and providing written informed consent.

Exclusion Criteria:

-Not being the primary caregiver of the palliative care patient. Providing caregiving services for payment. Having cognitive, visual, auditory, or communication difficulties that prevent understanding the data collection instruments or using the program despite the support provided.

Concurrently participating in another structured psychoeducational or psychosocial support program for caregivers.

Not having the capacity to participate in the study or provide informed consent.

-

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Nurse-Led, Generative AI-Supported Individualized Psychosocial Support Program
Participants will receive routine care and information provided by the institution in addition to a six-week, nurse-led, generative AI-supported individualized psychosocial support program. The program consists of six modules addressing adaptation to the caregiving role and care readiness, understanding care needs and coping with uncertainty, stress and emotion regulation, adaptive coping and problem solving, self-care and social support, and meaning-making and strengthening personal resources. Generative AI will be used as a nurse-supervised psychoeducational support tool based on expert-validated content and predefined safety rules. The content will be individualized according to caregivers' psychosocial needs, caregiving experiences, responses during the program, and basic characteristics of the patient's care needs.
A six-week, nurse-led, generative AI-supported individualized psychosocial support program for primary caregivers of palliative care patients. The program consists of six modules: (1) adaptation to the caregiving role and care readiness, (2) understanding caregiving needs and coping with uncertainty, (3) stress management and emotion regulation, (4) adaptive coping and problem solving, (5) self-care and social support, and (6) meaning-making and strengthening personal resources. Standardized core content will be individualized according to caregivers' psychosocial needs, caregiving experiences, responses during the program, and basic characteristics of the patient's care needs. Generative AI will be used as a nurse-supervised psychoeducational support tool based on expert-validated content and predefined safety rules.
Experimental: Routine Care and Information
Participants will receive routine care and information provided by the institution during the study period. They will not receive the nurse-led, generative AI-supported individualized psychosocial support program
Participants will receive routine care and information provided by the institution during the study period. They will not receive the nurse-led, generative AI-supported individualized psychosocial support program.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Baseline (pretest) and immediately after the six-week intervention (posttest)
Zeitfenster: Baseline (pretest) and immediately after the six-week intervention (posttest)
Care readiness of primary caregivers will be assessed using the Caregiver Readiness Scale. The scale evaluates caregivers' perceived readiness to fulfill the physical, emotional, and practical requirements of the caregiving role and to cope with caregiving-related stress. Higher scores indicate a higher level of care readiness.
Baseline (pretest) and immediately after the six-week intervention (posttest)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Baseline (pretest) and immediately after the six-week intervention (posttest)
Zeitfenster: Baseline (pretest) and immediately after the six-week intervention (posttest)
Psychological resilience of primary caregivers will be assessed using the Psychological Resilience Scale for Adults. The scale consists of 33 items and evaluates self-perception, future perception, structural style, social competence, family cohesion, and social resources. Higher scores indicate higher psychological resilience.
Baseline (pretest) and immediately after the six-week intervention (posttest)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

  • 1. Basım, H. N., & Çetin, F. (2011). Yetişkinler için Psikolojik Dayanıklılık Ölçeği'nin güvenilirlik ve geçerlilik çalışması. Türk Psikiyatri Dergisi, 22(2), 104-114. 2. Bauman, C., Årestedt, K., Wallin, V., Häger Tibell, L., Fürst, P., Hudson, P., Kreicbergs, U., & Alvariza, A. (2025). Web-based psychoeducational intervention to improve family caregiver preparedness in specialized palliative home care: A randomized controlled trial. Psycho-Oncology, 34, e70202. https://doi.org/10.1002/pon.70202 3. Bilgin, A., & Özdemir, L. (2022). Interventions to improve the preparedness to care for family caregivers of cancer patients: A systematic review and meta-analysis. Cancer Nursing, 45(3), E689-E705. https://doi.org/10.1097/NCC.0000000000001014 4. Bozkurt, S., Fereydooni, S., Kar, I., Diop Chalmers, C., Leslie, S. L., Pathak, R., Walling, A. M., Lindvall, C., Lorenz, K., Parikh, R., Quest, T., Giannitrapani, K., & Kavalieratos, D. (2025). AI in palliative care: A scoping review of foundational gaps and future directions for responsible innovation. Journal of Pain and Symptom Management, 70(6), e394-e418. https://doi.org/10.1016/j.jpainsymman.2025.08.009 5. Caetano, P., Querido, A., & Laranjeira, C. (2024). Preparedness for caregiving role and telehealth use to provide informal palliative home care in Portugal: A qualitative study. Healthcare, 12(19), 1915. https://doi.org/10.3390/healthcare12191915 6. Cheng, Q., Ng, M. S. N., Choi, K. C., Chen, Y., Liu, G., & So, W. K. W. (2024). A mobile instant messaging-delivered psychoeducational intervention for cancer caregivers: A randomized clinical trial. JAMA Network Open, 7(2), e2356522. https://doi.org/10.1001/jamanetworkopen.2023.56522 7. Dionne-Odom, J. N., Azuero, A., Taylor, R. A., Wells, R. D., Hendricks, B. A., Bechthold, A. C., Reed, R. D., Harrell, E. R., Dosse, C. K., Engler, S., McKie, P., Ejem, D., Bakitas, M. A., & Rosenberg, A. R. (2021). Resilience, preparedness, and distress among family caregivers of patients w

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

20. Oktober 2026

Primärer Abschluss (Geschätzt)

15. November 2026

Studienabschluss (Geschätzt)

20. März 2027

Studienanmeldedaten

Zuerst eingereicht

28. August 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

28. August 2026

Zuerst gepostet (Tatsächlich)

2. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

2. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

28. August 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Beschreibung des IPD-Plans

At this stage, a decision regarding the sharing of individual participant-level data with other researchers has not yet been made. Any future data-sharing decision will be made in accordance with applicable ethical requirements, participant consent, data protection regulations, and institutional policies.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren